Tonix Pharmaceuticals Holding TNXP
NASDAQ TNXP
$9.65 -0.25 (-2.53%)
At close: Sep 29, 2026 · 4:00 PM EDT

Tonix Pharmaceuticals Holding (TNXP) Share-based Compensation (2011 - 2026)

Updated

Tonix Pharmaceuticals Holding (TNXP) posted Share-based Compensation of $2.26 million for Q2 2026, up 58.5% from $1.42 million a year earlier and up 14.5% from the prior quarter.

Analysis

Tonix Pharmaceuticals Holding (TNXP) Share-based Compensation (2011 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Tonix Pharmaceuticals Holding was $7.94 million, up 87.3% year-over-year; for FY2025, it was $6.02 million, up 25.9% from FY2024.

  • Annual Share-based Compensation shows a five-year compound annual growth rate of 15.9% (FY2020 to FY2025).
  • In prior years, Tonix Pharmaceuticals Holding's Share-based Compensation was $4.78 million in FY2024 (-48.5%), $9.28 million in FY2023 (-15.0%), $10.91 million in FY2022 (+38.2%) and $7.9 million in FY2021 (+174.7%).
  • The Q2 2026 figure stands as the highest quarterly Share-based Compensation since Q2 2023.
  • On a year-over-year basis, Share-based Compensation has increased in each of the last five quarters, with growth averaging 29.6% over the last eight quarters.
  • The strongest year-over-year quarter for Share-based Compensation in the past five years was Q4 2021, with growth of 163.6%; the weakest was Q4 2024, with a decline of 56.1%.
  • According to Business Quant data, Share-based Compensation for the three prior quarters was $1.97 million (Q1 2026), $1.79 million (Q4 2025) and $1.92 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Tonix Pharmaceuticals Holding 166.24 Mn 166.24 Mn 12.84 Mn 2.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.26 Mn
Mar 31, 2026 1.97 Mn
Dec 31, 2025 1.79 Mn
Sep 30, 2025 1.92 Mn
Jun 30, 2025 1.42 Mn
Mar 31, 2025 882,000.00
Dec 31, 2024 894,000.00
Sep 30, 2024 1.04 Mn
Jun 30, 2024 1.15 Mn
Mar 31, 2024 1.69 Mn
Dec 31, 2023 2.04 Mn
Sep 30, 2023 2.08 Mn
Jun 30, 2023 2.36 Mn
Mar 31, 2023 2.79 Mn
Dec 31, 2022 2.72 Mn
Sep 30, 2022 2.77 Mn
Jun 30, 2022 2.81 Mn
Mar 31, 2022 2.62 Mn
Dec 31, 2021 2.30 Mn
Sep 30, 2021 2.30 Mn
API Access

Tonix Pharmaceuticals Holding Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TNXP&period=max&api_key=YOUR_API_KEY